Dedicated ECPs move into Canada

Canadian family planners are seeing the emergence of dedicated emergency contraceptive pills (ECP), with one now on the market and another under regulatory review by Canadian health officials.

Preven, the ethinyl estradiol/levonorgestrel ECP from Gynétics of Belle Mead, NJ, has been launched for Canadian marketing by Roberts Pharmaceutical Canada of Toronto. It received Canadian regulatory clearance in March 1999.

Paladin Labs of Montreal, Quebec, has exclusive Canadian distribution rights from Women’s Capi tal Corp. of Bellevue, WA, for Plan B, the company’s levonorgestrel ECP. Plan B is under regula- tory review by Canadian health authorities.